Parker-Hannifin Other Non-Current Liabilities decreased by 7.1% to $717.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.5%, from $692.64M to $717.00M. Over 4 years (FY 2021 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 3.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $639.36M | $618.08M | $600.45M | $583.23M | $521.90M | $895.79M | $898.70M | $960.42M | $893.36M | $671.54M | $714.84M | $709.55M | $726.00M | $715.95M | $684.40M | $692.64M | $733.00M | $753.00M | $772.00M | $717.00M |
| QoQ Change | — | -3.3% | -2.9% | -2.9% | -10.5% | +71.6% | +0.3% | +6.9% | -7.0% | -24.8% | +6.4% | -0.7% | +2.3% | -1.4% | -4.4% | +1.2% | +5.8% | +2.7% | +2.5% | -7.1% |
| YoY Change | — | — | — | — | -18.4% | +44.9% | +49.7% | +64.7% | +71.2% | -25.0% | -20.5% | -26.1% | -18.7% | +6.6% | -4.3% | -2.4% | +1.0% | +5.2% | +12.8% | +3.5% |